Nu Skin Enterprises, Inc. (NUS) Stock Score, Valuation & Financial Research
Nu Skin Enterprises, Inc. is in the Consumer Defensive sector and Household & Personal Products industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 66/100.
Quick answer for NUS
Nu Skin Enterprises, Inc. currently has a Wall Street Score of 66/100. The stored market price is $4.87. Its financial score is 17/100. Its valuation score is 100/100. These figures are a research snapshot, not a buy or sell recommendation.
What Nu Skin Enterprises, Inc. does
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development
NUS financial snapshot
- Wall Street Score:
- 66/100
- Current price:
- $4.87
- Market capitalization:
- $236.4M
- Revenue:
- $1.44B
- Net income:
- $54.5M
- Free cash flow:
- $46.0M
- Cash:
- $198.7M
- Total debt:
- $277.6M
- EPS:
- 3.25
- P/E ratio:
- 1.5x
- Financial score:
- 17/100
- Valuation score:
- 100/100
- Revenue score:
- 37/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $46.0M, showing positive cash generation.
- The balance sheet shows $198.7M of cash versus $277.6M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 17/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research NUS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.